PIERIS PHARMACEUTICALS, INC.·4

Feb 28, 5:23 PM ET

Yoder Stephen S. 4

4 · PIERIS PHARMACEUTICALS, INC. · Filed Feb 28, 2019

Insider Transaction Report

Form 4
Period: 2019-02-26
Yoder Stephen S.
DirectorCEO and President
Transactions
  • Award

    Stock Options (Right to Buy)

    2019-02-26+380,000380,000 total
    Exercise: $3.09Exp: 2029-02-26Common Stock (380,000 underlying)
Footnotes (1)
  • [F1]The option vests as to 25% of the option shares on February 26, 2020 and vests as to an additional 6.25% of the option shares at the end of each successive three-month period thereafter.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT